初级骨髓大B细胞淋巴瘤的遗传特征
Yi-Chen Yeh1, Kung-Chao Chang2, Chih-Yi Hsu3
1Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Pathology, research and practice
|August 7, 2025
概括
主要骨髓大B细胞淋巴瘤 (PBM-LBCL) 具有独特的遗传特征,使其与扩散大B细胞淋巴瘤 (DLBCL) 不同. BTG1突变与PBM-LBCL的预后不佳有关,这表明了潜在的生物标志物.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 主要骨髓大B细胞淋巴瘤 (PBM-LBCL) 是一种罕见的血液恶性瘤,遗传基础不明.
- 传统的扩散性大B细胞淋巴瘤 (DLBCL) 具有二次骨髓参与,可以作为比较对象来理解PBM-LBCL独特的生物学.
研究的目的:
- 通过全外因子测序来划分PBM-LBCL的遗传景观.
- 识别明显的分子特征和潜在的预后标记,区分PBM-LBCL与DLBCL与二次骨髓参与.
主要方法:
- 在19例PBM-LBCL病例和11例DLBCL病例的骨髓样本上进行了全外体序列测序,其中包括二次骨髓参与.
- 分析了临床病理学特征和生存数据,并在两组之间进行了比较.
- 鉴定出与临床结果相关的突变特征和特定基因突变.
主要成果:
- 在PBM-LBCL和DLBCL之间的临床病理特征中没有观察到显著差异,IPI得分和治疗方案预测了存活率.
- 一个独特的16基因突变特征将PBM-LBCL与DLBCL区分开来,在每个组中都有特定的基因突变.
- 在COL5A3,PCNT,HMCN2和OSBPL10中发生的突变与血细胞淋巴细胞瘤 (HLH) 相关,而BTG1突变与预后不佳相关.
结论:
- PBM-LBCL具有独特的遗传特征,与DLBCL不同,具有二级骨髓参与,具有特定的16基因特征.
- BTG1突变代表了PBM-LBCL的显著不良预后因素,可能作为治疗标或生物标志物.
- 这些发现增强了对PBM-LBCL分子异质性的理解,并有助于预后分层.
相关概念视频
Primary Lymphoid Organs
6.1K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
6.1K
Bone Marrow Sampling and Transplants
500
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
500
Cells of the Adaptive Immune Response
4.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.1K
Disorders of Leukocytes
1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K


